Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Journal of Digital Imaging
|
July 26, 2011
Quantified visual scoring of metastatic melanoma patient treatment response using computed tomography: improving on the current standard
Ronald H Gottlieb, Elizabeth Krupinski, Pavani Chalasani, et al.
Journal of the American Academy of Dermatology
|
June 18, 2011
Metastatic cutaneous squamous cell carcinoma responding to erlotinib therapy
Candace Engelhardt, Clara Curiel-Lewandrowski, James Warneke, et al.
Archives of Dermatology
|
April 18, 2012
Erythematous annular plaques on the trunk
Lindsay LaPresto, Lee Cranmer, Christof P Erickson, et al.
JAMA Dermatology
|
April 5, 2013
A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil
Lindsay LaPresto, Lee Cranmer, Lynne Morrison, et al.
Journal for Immunotherapy of Cancer
|
July 19, 2017
Angiosarcoma treated successfully with anti-PD-1 therapy - a case report
Simran Sindhu, Lana H Gimber, Lee Cranmer, et al.
Journal of Pediatric Hematology/Oncology
|
December 2, 2016
Recurrent Osteosarcoma Presenting as an Isolated Bone Marrow Relapse
Julia Liu, Lee Cranmer, Brandon T Larsen, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
October 20, 2009
Melanoma high-risk families' perceived health care provider risk communication
Lois J Loescher, Janice D Crist, Lee Cranmer, et al.
Archives of Dermatology
|
February 23, 2011
Multiple primary cutaneous melanomas in Li-Fraumeni syndrome
Clara Curiel-Lewandrowski, Larisa Sotinsky Speetzen, Lee Cranmer, et al.
Investigational New Drugs
|
October 16, 2009
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
Karl D Lewis, Wolfram Samlowski, John Ward, et al.
Seminars in Oncology
|
February 23, 2010
The role of anti-tumor necrosis factor receptor agents in cancer survivors: does the risk justify the benefit?
Paul Chapman, Lee Cranmer, W G Dixon, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Journal of Digital Imaging
|
July 26, 2011
Quantified visual scoring of metastatic melanoma patient treatment response using computed tomography: improving on the current standard
Ronald H Gottlieb, Elizabeth Krupinski, Pavani Chalasani, et al.
Journal of the American Academy of Dermatology
|
June 18, 2011
Metastatic cutaneous squamous cell carcinoma responding to erlotinib therapy
Candace Engelhardt, Clara Curiel-Lewandrowski, James Warneke, et al.
Archives of Dermatology
|
April 18, 2012
Erythematous annular plaques on the trunk
Lindsay LaPresto, Lee Cranmer, Christof P Erickson, et al.
JAMA Dermatology
|
April 5, 2013
A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil
Lindsay LaPresto, Lee Cranmer, Lynne Morrison, et al.
Journal for Immunotherapy of Cancer
|
July 19, 2017
Angiosarcoma treated successfully with anti-PD-1 therapy - a case report
Simran Sindhu, Lana H Gimber, Lee Cranmer, et al.
Journal of Pediatric Hematology/Oncology
|
December 2, 2016
Recurrent Osteosarcoma Presenting as an Isolated Bone Marrow Relapse
Julia Liu, Lee Cranmer, Brandon T Larsen, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
October 20, 2009
Melanoma high-risk families' perceived health care provider risk communication
Lois J Loescher, Janice D Crist, Lee Cranmer, et al.
Archives of Dermatology
|
February 23, 2011
Multiple primary cutaneous melanomas in Li-Fraumeni syndrome
Clara Curiel-Lewandrowski, Larisa Sotinsky Speetzen, Lee Cranmer, et al.
Investigational New Drugs
|
October 16, 2009
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
Karl D Lewis, Wolfram Samlowski, John Ward, et al.
Seminars in Oncology
|
February 23, 2010
The role of anti-tumor necrosis factor receptor agents in cancer survivors: does the risk justify the benefit?
Paul Chapman, Lee Cranmer, W G Dixon, et al.
Page
of 3